首页 > 最新文献

Minerva Respiratory Medicine最新文献

英文 中文
The place of blood patch pleurodesis in the management of inoperable spontaneous pneumothorax 不能手术的自发性气胸的治疗中胸膜贴片术的地位
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.21.01964-1
M. Lakranbi, M. Rhaouti, Fatima E. Lamouime, S. Rabiou, Maha Tachaouine, Y. Ouadnouni, M. Smahi
{"title":"The place of blood patch pleurodesis in the management of inoperable spontaneous pneumothorax","authors":"M. Lakranbi, M. Rhaouti, Fatima E. Lamouime, S. Rabiou, Maha Tachaouine, Y. Ouadnouni, M. Smahi","doi":"10.23736/s2784-8477.21.01964-1","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01964-1","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"1 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86641731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fetal inflammatory response syndrome and postnatal multi-system inflammatory syndrome in COVID-19-positive neonates covid -19阳性新生儿的胎儿炎症反应综合征和产后多系统炎症综合征
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.21.01961-6
Meenakshi S. Kushwah, Arunkrishnan Balaravi, L. Venugopalan, Sreekanth Ramashenoy, Anita Chrisbina, Monisha Prabhakarn, Sumaiya Alauddin, Munmun Sahney, Manoj K. Deenadayalan, P. Petchimuthu
Increasing incidences of COVID-19 in pregnant women, and lack of data regarding vertical transmission and extent of disease in newborns, has raised a concern towards it. The fetal inflammatory response syndrome (FIRS) and multisystem inflammatory syndrome in neonates (MIS-N) is also not a well-known entity till now. This case report of two newborns is an effort to describe the different clinical scenarios of COVID-19 and its response to the treatment. The first case suggests the possible in utero transmission which is a rare mode of infection as evident from previous data and the inflammatory response, getting treated by the use of immunotherapy and antivirals. The second case suggest the horizontal transmission acquired postnatally and the severity of multisystem inflammatory syndrome in neonate which could not be revived in spite all the efforts in treatment.
孕妇中COVID-19的发病率不断上升,以及缺乏关于新生儿垂直传播和疾病程度的数据,引起了人们对这一问题的关注。胎儿炎症反应综合征(FIRS)和新生儿多系统炎症综合征(MIS-N)目前也是一个不为人所知的实体。本两例新生儿病例报告旨在描述COVID-19的不同临床情况及其对治疗的反应。第一个病例表明可能在子宫内传播,这是一种罕见的感染模式,从以前的数据和炎症反应中可以看出,通过使用免疫疗法和抗病毒药物进行治疗。第二个病例提示新生儿的水平传播是在出生后获得的,多系统炎症综合征的严重程度,无论如何努力治疗都无法恢复。
{"title":"Fetal inflammatory response syndrome and postnatal multi-system inflammatory syndrome in COVID-19-positive neonates","authors":"Meenakshi S. Kushwah, Arunkrishnan Balaravi, L. Venugopalan, Sreekanth Ramashenoy, Anita Chrisbina, Monisha Prabhakarn, Sumaiya Alauddin, Munmun Sahney, Manoj K. Deenadayalan, P. Petchimuthu","doi":"10.23736/s2784-8477.21.01961-6","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01961-6","url":null,"abstract":"Increasing incidences of COVID-19 in pregnant women, and lack of data regarding vertical transmission and extent of disease in newborns, has raised a concern towards it. The fetal inflammatory response syndrome (FIRS) and multisystem inflammatory syndrome in neonates (MIS-N) is also not a well-known entity till now. This case report of two newborns is an effort to describe the different clinical scenarios of COVID-19 and its response to the treatment. The first case suggests the possible in utero transmission which is a rare mode of infection as evident from previous data and the inflammatory response, getting treated by the use of immunotherapy and antivirals. The second case suggest the horizontal transmission acquired postnatally and the severity of multisystem inflammatory syndrome in neonate which could not be revived in spite all the efforts in treatment.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"72 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88909035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A successfully home-treated adverse reaction to cefepime in a geriatric patient 成功在家治疗老年患者对头孢吡肟的不良反应
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.21.01968-9
M. Patruno, S. Dragonieri, Francesca Addante, S. Patruno, P. Portincasa, P. Carratù
{"title":"A successfully home-treated adverse reaction to cefepime in a geriatric patient","authors":"M. Patruno, S. Dragonieri, Francesca Addante, S. Patruno, P. Portincasa, P. Carratù","doi":"10.23736/s2784-8477.21.01968-9","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01968-9","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"178 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77768754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcomes in patients with severe respiratory failure due to novel coronavirus disease 2019 treated with non-invasive respiratory support: observational, prospective study 无创呼吸支持治疗2019新型冠状病毒病所致严重呼吸衰竭患者的临床结果:观察性、前瞻性研究
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.21.01959-8
G. Segrelles-Calvo, Estefanía Llopis-Pastor, Esther ANTÓN-DÍAZ, I. Escribano, L. Rey, Glauber Ribeiro de Sousa Araújo, Marta Hernandez-Hernandez, Nestór RODRÍGUEZ-MELEAN, C. Zamarro, Javier Carrillo Hernández-Rubio, Elena ALONSO-VILLÁN, S. Frases, Mercedes García-Salmones
BACKGROUND: In the present study we aimed to analyze the response to non-invasive respiratory support in patients stratified with acute respiratory failure due to novel coronavirus disease. METHODS: A prospective, observational study was carried out in Hospital Universitario Rey Juan Carlos from February 1st to June 30th, 2020. The study was approved by the Ethics Committee of the Fundacion Jimenez Diaz. We included patients over 18 years of age with confirmed SARS-CoV-2 infection who required non-invasive respiratory support (N.=130). We classified patients included in the sample according to the three clinical scenarios established by the Spanish Respiratory Society. RESULTS: The mean age of the patients was 64.3 +/- 12.9 years;43.8% were older than 70, and the majority were male (N.=88;67.7%). Eighty percent of the study population (N.=104) presented comorbidities. The most used device was the continuous positive airway pressure (54.6%, N.=71). Non-invasive respiratory support-based treatment avoided Intensive Care Unit admission in 68% of the acute respiratory failure cases studied. Treatment-failure occurred in 43.8% of patients (37% clinical scenario 1, de-novo acute respiratory failure, P=0.04) and the overall rate of mortality was 36.2% (14.8% clinical scenario 1, P<0.00001). CONCLUSIONS: The used of non-invasive respiratory support was safe and clinically effective treatment (68% of ICU admissions prevented, lower rate of TF than that reported for other viral pneumonias, and a mortality rate of 14.8% within clinical scenario 1). Non-invasive respiratory support may be considered a first-line therapy for patients with severe COVID-19.
背景:本研究旨在分析新型冠状病毒感染急性呼吸衰竭分层患者对无创呼吸支持的反应。方法:于2020年2月1日至6月30日在雷胡安卡洛斯大学医院进行一项前瞻性观察性研究。这项研究得到了希门尼斯·迪亚兹基金会伦理委员会的批准。我们纳入了18岁以上确诊为SARS-CoV-2感染且需要非侵入性呼吸支持的患者(n =130)。我们根据西班牙呼吸学会建立的三种临床情景对纳入样本的患者进行分类。结果:患者平均年龄64.3±12.9岁,年龄≥70岁者占43.8%,以男性居多(n =88;67.7%)。80%的研究人群(n =104)出现合并症。使用最多的器械是持续气道正压通气(54.6%,n =71)。在研究的68%的急性呼吸衰竭病例中,无创呼吸支持治疗避免了重症监护病房的入院。43.8%的患者出现治疗失败(37%的临床情景1,新生急性呼吸衰竭,P=0.04),总死亡率为36.2%(14.8%的临床情景1,P<0.00001)。结论:使用无创呼吸支持是一种安全且临床有效的治疗方法(68%的ICU入院率被预防,TF发生率低于其他病毒性肺炎,临床情景1的死亡率为14.8%)。无创呼吸支持可被视为重症COVID-19患者的一线治疗方法。
{"title":"Clinical outcomes in patients with severe respiratory failure due to novel coronavirus disease 2019 treated with non-invasive respiratory support: observational, prospective study","authors":"G. Segrelles-Calvo, Estefanía Llopis-Pastor, Esther ANTÓN-DÍAZ, I. Escribano, L. Rey, Glauber Ribeiro de Sousa Araújo, Marta Hernandez-Hernandez, Nestór RODRÍGUEZ-MELEAN, C. Zamarro, Javier Carrillo Hernández-Rubio, Elena ALONSO-VILLÁN, S. Frases, Mercedes García-Salmones","doi":"10.23736/s2784-8477.21.01959-8","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01959-8","url":null,"abstract":"BACKGROUND: In the present study we aimed to analyze the response to non-invasive respiratory support in patients stratified with acute respiratory failure due to novel coronavirus disease. METHODS: A prospective, observational study was carried out in Hospital Universitario Rey Juan Carlos from February 1st to June 30th, 2020. The study was approved by the Ethics Committee of the Fundacion Jimenez Diaz. We included patients over 18 years of age with confirmed SARS-CoV-2 infection who required non-invasive respiratory support (N.=130). We classified patients included in the sample according to the three clinical scenarios established by the Spanish Respiratory Society. RESULTS: The mean age of the patients was 64.3 +/- 12.9 years;43.8% were older than 70, and the majority were male (N.=88;67.7%). Eighty percent of the study population (N.=104) presented comorbidities. The most used device was the continuous positive airway pressure (54.6%, N.=71). Non-invasive respiratory support-based treatment avoided Intensive Care Unit admission in 68% of the acute respiratory failure cases studied. Treatment-failure occurred in 43.8% of patients (37% clinical scenario 1, de-novo acute respiratory failure, P=0.04) and the overall rate of mortality was 36.2% (14.8% clinical scenario 1, P<0.00001). CONCLUSIONS: The used of non-invasive respiratory support was safe and clinically effective treatment (68% of ICU admissions prevented, lower rate of TF than that reported for other viral pneumonias, and a mortality rate of 14.8% within clinical scenario 1). Non-invasive respiratory support may be considered a first-line therapy for patients with severe COVID-19.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"38 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74109346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of gender differences on pulmonary diseases and their clinical implications 性别差异对肺部疾病的影响及其临床意义
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.22.02013-7
C. Martelli, Roberto Rana, F. Alfano, Chiara Arena, F. Baraldi, Tommaso Bigoni, S. Casanova, M. Cometa, Martina Pompignoli, Federica Santoli, Enea Tazzari, Francesca Urbani, A. Ursitti, M. Contoli, A. Papi
Male and female patients are usually considered clinically equivalent from a diagnostic and treatment point of view, and no relevance is given to the differences in morphometry and physiology of the respiratory system between the two sexes. This is a major limitation in the understanding of the pathology and effective management of multiple respiratory ailments. The present review analyses the available literature on the major respiratory diseases from a gender-difference perspective. We performed our research using the PubMed Advanced Browser. The research for each clinical condition was conducted by using the key words "gender" OR "sex." For example, considering asthma, the search criteria were "asthma" AND "gender" OR "sex." All the respiratory diseases considered in this review are deeply influenced by the sex of the patient in diverse ways. For example, in women, estrogens could play a protective role in some conditions, like IPF, while in others they are associated with increased risk of disease development, as in some types of severe asthma. Psychological symptoms are more frequent in women with obstructive conditions such as OSAS, COPD, and asthma. Despite the available evidence, current therapeutic strategies largely ignore these differences, and data on gender-weighted interventions are still scarce. Sex differences are common in respiratory diseases. They have largely been ignored in clinical approaches towards these diseases. Evidence has been generated in the last few decades in favor of gender-based diagnostic and therapeutic strategies.
从诊断和治疗的角度来看,通常认为男性和女性患者在临床上是等同的,而没有考虑到两性之间呼吸系统形态学和生理学的差异。这是对多种呼吸系统疾病的病理和有效管理的理解的主要限制。本文从性别差异的角度分析了主要呼吸系统疾病的现有文献。我们使用PubMed高级浏览器进行研究。每一种临床症状的研究都是用关键词“性别”或“性”来进行的。例如,考虑到哮喘,搜索条件是“哮喘”和“性别”或“性别”。在这篇综述中考虑的所有呼吸系统疾病都在不同的方面深受患者性别的影响。例如,对女性来说,雌激素在某些情况下可以发挥保护作用,如IPF,而在其他情况下,它们与疾病发展的风险增加有关,如在某些类型的严重哮喘中。心理症状在患有阻塞性睡眠呼吸暂停症、慢性阻塞性肺病和哮喘等阻塞性疾病的女性中更为常见。尽管已有证据,但目前的治疗策略在很大程度上忽略了这些差异,性别加权干预措施的数据仍然很少。性别差异在呼吸道疾病中很常见。在治疗这些疾病的临床方法中,它们在很大程度上被忽视了。在过去的几十年里,已经产生了支持基于性别的诊断和治疗策略的证据。
{"title":"The impact of gender differences on pulmonary diseases and their clinical implications","authors":"C. Martelli, Roberto Rana, F. Alfano, Chiara Arena, F. Baraldi, Tommaso Bigoni, S. Casanova, M. Cometa, Martina Pompignoli, Federica Santoli, Enea Tazzari, Francesca Urbani, A. Ursitti, M. Contoli, A. Papi","doi":"10.23736/s2784-8477.22.02013-7","DOIUrl":"https://doi.org/10.23736/s2784-8477.22.02013-7","url":null,"abstract":"Male and female patients are usually considered clinically equivalent from a diagnostic and treatment point of view, and no relevance is given to the differences in morphometry and physiology of the respiratory system between the two sexes. This is a major limitation in the understanding of the pathology and effective management of multiple respiratory ailments. The present review analyses the available literature on the major respiratory diseases from a gender-difference perspective. We performed our research using the PubMed Advanced Browser. The research for each clinical condition was conducted by using the key words \"gender\" OR \"sex.\" For example, considering asthma, the search criteria were \"asthma\" AND \"gender\" OR \"sex.\" All the respiratory diseases considered in this review are deeply influenced by the sex of the patient in diverse ways. For example, in women, estrogens could play a protective role in some conditions, like IPF, while in others they are associated with increased risk of disease development, as in some types of severe asthma. Psychological symptoms are more frequent in women with obstructive conditions such as OSAS, COPD, and asthma. Despite the available evidence, current therapeutic strategies largely ignore these differences, and data on gender-weighted interventions are still scarce. Sex differences are common in respiratory diseases. They have largely been ignored in clinical approaches towards these diseases. Evidence has been generated in the last few decades in favor of gender-based diagnostic and therapeutic strategies.","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"52 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87748400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Increasing or decreasing the expression of miR-199, miR-210 and miR-143 and the effect on cell growth, apoptosis and angiogenesis through the expression of target genes in non-small cell lung cancer 增高或降低miR-199、miR-210和miR-143的表达,通过靶基因的表达对非小细胞肺癌细胞生长、凋亡和血管生成的影响
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.21.01970-7
Mohammad H. Talischi, A. Mohamadnia, M. Mahmoodi, N. Bahrami, Abdollah Farhadi Nasab
{"title":"Increasing or decreasing the expression of miR-199, miR-210 and miR-143 and the effect on cell growth, apoptosis and angiogenesis through the expression of target genes in non-small cell lung cancer","authors":"Mohammad H. Talischi, A. Mohamadnia, M. Mahmoodi, N. Bahrami, Abdollah Farhadi Nasab","doi":"10.23736/s2784-8477.21.01970-7","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01970-7","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"128 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74488441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Paraoxonase-1 in stable chronic obstructive pulmonary disease: a systematic review and meta-analysis 对氧磷酶-1在稳定型慢性阻塞性肺疾病中的作用:一项系统综述和荟萃分析
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-08-01 DOI: 10.23736/s2784-8477.22.01999-4
E. Zinellu, A. Zinellu, M. C. Pau, A. Fois, S. Mellino, A. Mangoni, C. Carru, P. Pirina
{"title":"Paraoxonase-1 in stable chronic obstructive pulmonary disease: a systematic review and meta-analysis","authors":"E. Zinellu, A. Zinellu, M. C. Pau, A. Fois, S. Mellino, A. Mangoni, C. Carru, P. Pirina","doi":"10.23736/s2784-8477.22.01999-4","DOIUrl":"https://doi.org/10.23736/s2784-8477.22.01999-4","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"47 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87369583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rapidly fatal disseminated histoplasmosis presenting as acute respiratory distress syndrome in a patient with HIV 迅速致命的弥散性组织胞浆菌病表现为急性呼吸窘迫综合征的患者HIV
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-05-01 DOI: 10.23736/s2784-8477.21.01951-3
M. Garcia
{"title":"Rapidly fatal disseminated histoplasmosis presenting as acute respiratory distress syndrome in a patient with HIV","authors":"M. Garcia","doi":"10.23736/s2784-8477.21.01951-3","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01951-3","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"8 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81419146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant pneumomediastinum and pneumoneck due to self-induced vomiting: cues from a case 自体呕吐并发纵隔气肿和肺颈:来自一个病例的线索
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-05-01 DOI: 10.23736/s2784-8477.21.01950-1
A. Caranti, S. Savini, Anna Bonsembiante, C. Bianchini, A. Ciorba, S. Pelucchi
{"title":"Concomitant pneumomediastinum and pneumoneck due to self-induced vomiting: cues from a case","authors":"A. Caranti, S. Savini, Anna Bonsembiante, C. Bianchini, A. Ciorba, S. Pelucchi","doi":"10.23736/s2784-8477.21.01950-1","DOIUrl":"https://doi.org/10.23736/s2784-8477.21.01950-1","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"150 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77433778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and management of patients with α1-antitrypsin deficiency: an Italian perspective α - 1抗胰蛋白酶缺乏症患者的诊断和治疗:意大利视角
IF 2.4 Q4 RESPIRATORY SYSTEM Pub Date : 2022-05-01 DOI: 10.23736/s2784-8477.22.01995-7
S. Aliberti, F. Amati, A. Annunziata, F. Arcoleo, P. Baderna, F. Bini, Chiara F. Carraro, L. Iannacci, S. Lo Cicero, G. Passalacqua, D. Piloni, G. Scioscia, C. Seebacher, E. Sortino, A. Spacone, A. Vianello
{"title":"Diagnosis and management of patients with α1-antitrypsin deficiency: an Italian perspective","authors":"S. Aliberti, F. Amati, A. Annunziata, F. Arcoleo, P. Baderna, F. Bini, Chiara F. Carraro, L. Iannacci, S. Lo Cicero, G. Passalacqua, D. Piloni, G. Scioscia, C. Seebacher, E. Sortino, A. Spacone, A. Vianello","doi":"10.23736/s2784-8477.22.01995-7","DOIUrl":"https://doi.org/10.23736/s2784-8477.22.01995-7","url":null,"abstract":"","PeriodicalId":29817,"journal":{"name":"Minerva Respiratory Medicine","volume":"34 1","pages":""},"PeriodicalIF":2.4,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76152150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Minerva Respiratory Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1